0Q15.LSE Abbott Laboratories

Healthcare Medical Devices London Exchange
109.66 USD
Close of Nov 3, 2026
80.97 128.80
Market cap
USD 191B
P/E
14.2x
P/B
3.60x
ROE
8.3%
Dividend yield
2.16%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Mar 2026.

Is 0Q15.LSE undervalued?

Graham number
Price109.66
Graham value72.77
Premium50.7%

0Q15.LSE trades 50.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Abbott Laboratories fundamental analysis

No fundamental analysis for Abbott Laboratories yet.

Abbott Laboratories stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hor…

Full company profile